Ischemix, Inc., a pharmaceutical company, develops small molecule drugs for the treatment and prevention of ischemia-reperfusion injury. Its product includes CMX-2043, a cardio-protective drug that combines Akt pathway-mediated cell survival effects and anti-oxidant activity in a single small molecule, as well as is used for the prevention of peri-operative ischemia-reperfusion injury in patients undergoing elective percutaneous coronary intervention procedures. The company’s drugs also protect against the damaging effects associated with ischemia in brain and other organs. Ischemix, Inc. was formerly known as CereMedix, Inc. and changed its name to Ischemix, Inc. in February 2006. The company was founded in 1999 and is headquartered in Maynard, Massachusetts.

Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy.

Sunstar, Inc. manufactures and sells skin care products. Its brands include Sareine, Equitance, Atopilogy, Kenkodojo, Ora, and Butler. The company was founded in February 1946 and is headquartered in Takatsuki-shi, Japan.

The Korea Atomic Energy Research Institute (KAERI) in Daejeon, South Korea was established in 1959 as the sole professional research-oriented institute for nuclear power in South Korea, and has rapidly built a reputation for research and development in various fields. In 1995 KAERI designed and constructed the nation's first multipurpose research reactor, HANARO based on the Canadian MAPLE design. KAERI is dedicated to finding a wide range of uses for atomic energy. As examples, KAERI developed the world's first radiopharmaceutical "Milican injection" for treating liver cancer.

Industry Academic Cooperation Foundation Hallym University is a private company headquartered in the South Korea. The firm provides office support services.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

BREONICS’ Exsanguinous Metabolic Support (EMS) technology radically broadens the criteria for organ donors to include the huge cohort of patients that die every year and are previously not considered for donation. EMS is the first and only technology that can overcome the technical barriers that limit access to these potential donors and will more than double the number of transplantable kidneys worldwide.

The University of Iowa Research Foundation (UIRF) - a 501C3 corporation - commercializes University of Iowa developed technologies and inventions through licensing and new venture formation, and manages the subsequent revenue stream.

Weihai Kangbao Biotechnology Development Co., Ltd., established on 2001-06-26, Business scope includes development,Commissioned production of food and Kangxing brand health food(Domestic Health Food Approval Certificate:Grape Seed Green Guard Capsules,Propolis Ginkgo Leaf Chromium Yeast Softgels,Perilla Oil Gynostemma Ginkgo Biloba Soft Capsules,Collagen CalciumD3Casein Phosphopeptide Soft Capsules,grape seed vitaminCGlucosamine Hydrochloride Capsules)(The validity period of the above health food is subject to the license);food sales;Cosmetic sales;First,two,Three types of medical device business;Disinfection supplies sales;Sanitary Products Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Apex Bioscience, Inc. develops patented products based upon hemoglobin and nitric oxide technologies. The company was founded by Joseph de Angelo on June 17, 1993 and is headquartered in Chapel Hill, NC.

Korea Food Research Institute is a global food R&D institution that contributes to the health of Korea.

Lishen Pharmaceutical Co., Ltd., established on 2012-11-12, Business scope includes general items:medicine,Technology research and development in the field of biological and medical devices,technical consulting,Technical Services,technology transfer;R&D of industrial enzyme preparations;Disinfectant sales(Free of Hazardous Chemicals);Cosmetics Retail;Cosmetics Wholesale;General merchandise sales;Sales of Class I Medical Devices;Sales of Class II Medical Devices;daily mask(non-medical)Sales;Medical Mask Retail;Wholesale medical masks;Retailing of protective equipment for healthcare workers;Wholesale of protective equipment for medical staff;Sales of hygiene products and single-use medical products;brand management;Research and development of bio-based material polymerization technology;Biochemical product technology research and development;Chemical product sales(No licensed chemical products);Specialty Chemicals Sales(Free of Hazardous Chemicals);Sales of bio-based materials;Sales of daily chemical products;internet sales(Except for products that require a license for sale);Information Technology Consulting Services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Drug internet information service;food business;Class III medical device business;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).(The branch office is located in:Drug retail(The business address is located in Yatai Road, Nanhu District, Jiaxing City, Zhejiang Province705NoAseat11building1111-2,1112-1)food production(The factory is located in Yatai Road, Nanhu District, Jiaxing City, Zhejiang Province522No21building2No2-3Floor))

Kureha Corp. engages in the manufacture and sale of chemical products for pharmaceuticals, agrochemicals, and packaging materials. It operates through the following segments: Functional Products, Chemical Products, Resin Products, Construction-related Business, and Others. The Functional Products segment produces Polyphenylene Sulfide (PPS) resin, Polyvinylidene Fluoride, and carbon products. The Chemical Products segment develops and markets industrial chemicals, pharmaceutical products, and pesticides. The Resin Products segment includes food packaging materials and household goods. The Construction-related Business segment deals with construction and engineering services. The Others segment covers environmental-related businesses and logistics. The company was founded on June 21, 1944 and is headquartered in Tokyo, Japan.

Korea Institute of Radiological & Medical Sciences specializes in radiation technology, research, development, genomics, and radiotherapy.